In Sarawak Malaysia, nasopharyngeal carcinoma is a very common male malignancy often presenting in advanced stages with distal metastasis. The great majority of these NPC patients are treated by radiotherapy in Sarawak General Hospital. Bone scans using 99m Tc were done on 41 of these patients over the period of nine months from July 2003 to March 2004. A Very low true positive rate of 9.8 % and relatively high false positive rate of 44% were found and this is mainly due to large numbers of benign diseases such as degenerative spines. The radiologists' correct report rate in true positive bone scans is 75% but their high uncertain report rates of 72% in false positive bone scans are also high, probably suggesting their caution in patients with benign diseases showing positive bone scans. Positive bone scans were found in 51.7 % (15/29) of the newly diagnosed patients, and 58 % (7/12 of the treated patients, suggesting that bone scans are sensitive for screening so as to help target the sites for XR imaging for confirmation of presence of metastasis. Based on 18 cases of false positive scans and 2 cases of true negative scans the specificity of bone scans in NPC is 10% which is low. As there were no cases of false negative scans found, the sensitivity of the bone scan could not be calculated. Moreover, this series compares well with the past reported series in terms of the positive and true positive bone scan rates.
INTRODUCTION
Nasopharyngeal carcinoma (NPC) tops the list of malignancy in Malaysia 1 . It ranks first in male malignancy in the State of Sarawak 2 , 3 . The majority of the NPC presented late in their advanced stages and often with distal metastasis, usually to the bones 2 , 3 . The great majority of these NPC patients are treated by radiotherapy in Sarawak General Hospital.
In 2003, a new practice of bone scan using 99m Tc started in Sarawak General Hospital and over the period of nine months from July 2003 to March 2004, 41 NPC patients had the bone scans and our experience in these is presented
METHOD
The NPC patients were selected consecutively including both new and treated patients. The scanner used was Siemen Ecam plus and Technecium (99mTc) the radio-active isotope used. The scan images were read and reported by qualified and trained Radiologists. The bone scans were requested by Specialists from the ENT department of the Hospital. The bone scan reports were checked by the ENT Specialists and the decisions made as to clinical correlation and any further definitive imaging studies. NPC stages were I, II, III, and IV, and early stages included I + II whereas advanced stages III + IV. True positive bone scan was when bone scan and XR imaging both positive; False positive bone scan when bone scan positive but XR imaging negative. True negative bone scan was when both bone scan and XR imaging negative whereas false negative bone scan was when bone scan negative but XR imaging positive.
RESULTS
41 NPC patients were included in the studies. The ages of the patients range from 18 to 88 years, with a mean age being 50.5. There were 29 newly diagnosed, 12 treated (old follow-up) patients. All 41 patients had bone scans & 22 of them had positive bone scans. These 22 patients had XR imaging subsequently and 10 of them had degenerative spine diseases.
4 of these 22 patients (9.8%of total 41 patients) had true positive bone scans, 1 in newly diagnosed early stages and 3 in treated patients all in advanced stages of NPC. 18 of these 21 patients (44%of total 41 patients) had false positive bone scans, 14 in newly diagnosed, 1 in early stages and 13 advanced stages, and 4 in treated patients all in advanced stages of NPC.
2 of the total 41 patients (4.9%) had true negative bone scans, both were treated patients in advanced stages of NPC. There were no patients with false negative bone scans in this series.
Distal bone pain was present in 6 of the 41 patients. Of these, 2 treated patients in advanced stages of the disease had positive bone scans, 2 had false positive bone scans, 1in a newly diagnosed patient in early stage and 1 treated one in advanced stage of the disease. The other 2 were treated ones in advanced stages and had true negative bone scans.
Radiologist reports were correct in 75% of true positive bone scans (3 out of 4), and in 17% of the false negative bone scans (3 out of 18). Radiologists' reports were uncertain in 25% (1 out of 4) of the true positive bone scans and in 72% (13 out of 18) of the false negative bone scans.
In 2 of the 18 (11%) false negative bone scan patients, the radiologist reports were incorrect.
DISCUSSION
The true positive rate of 9.8 % (4/41) is very low. The false positive rate of 44% is relatively high, and this is mainly due to large number of benign diseases (majority being degenerative spine diseases, 10 patients).
Although positive bone scans were found in 51.7 % (15/29) of the newly diagnosed patients, and 58 % (7/12 of the treated patients, true positive bone scans were found only in 3.6 %(1/29) and 25% (3/12) respectively. These findings seem to indicate that bone scans are sensitive for screening so as to help target the sites for XR imaging for confirmation if metastasis is present.
There were 18 cases with false positive scans and 2 cases with true negative scans in this series. This makes the specificity of bone scans in NPC to be 10%. As there were no cases of false negative scans, the sensitivity of the bone scan could not be calculated.
The radiologists' correct report rate of 75%(3/4) in true positive bone scans is high. Their high uncertain report rates of 72% (13/18) in false positive bone scans seem to suggest their caution in patients with benign diseases such as degenerative spines. These benign diseases also gave positive bone scans. Table 1 shows the comparison of the positive and true positive bone scan rates in this series with the reported series over the search period of past 15 years. 
SUMMARY
In this series, although false positive rate of bone scans is high due to relatively large number of benign diseases, the high rate of positive bone scans suggest that bone scans are sensitive for screening so as to help target the sites for XR imaging for confirmation if metastasis is present. As there were no cases of false negative scans, the sensitivity of the bone scan could not be calculated. Moreover, this series compare well with the past reported series in terms of the positive and true positive bone scan rates. 
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